Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Redhill Biophrma ADR (NQ: RDHL ) 0.3211 +0.0310 (+10.69%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Redhill Biophrma ADR < Previous 1 2 3 4 5 6 7 8 9 10 Next > 12 Health Care Stocks Moving In Monday's Intraday Session May 09, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday May 04, 2022 During Wednesday's trading, 435 companies set new 52-week lows. Via Benzinga RedHill Biopharma Says Opaganib Can Potentially Work Against COVID-19 Omicron Subvariants April 11, 2022 Via Benzinga RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea March 15, 2022 Via Benzinga 26 Stocks Moving in Thursday's Pre-Market Session April 21, 2022 Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:... Via Benzinga RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib April 11, 2022 Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The... From RedHill Biopharma Ltd Via AccessWire Redhill Biopharma: Q4 Earnings Insights March 17, 2022 Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Redhill Biopharma's Earnings: A Preview March 16, 2022 Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts... Via Benzinga 64 Biggest Movers From Yesterday March 18, 2022 Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:... Via Benzinga RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients March 01, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced topline results from the Phase 2 part of the Phase 2/3 study of RHB-107 (upamostat) in non-hospitalized... Via Benzinga Earnings Scheduled For March 17, 2022 March 17, 2022 Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is... Via Benzinga RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients February 07, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced results from two recently completed prespecified analyses from the oral opaganib Phase 2/3 study in hospitalized severe COVID-19. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 15, 2022 During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... Via Benzinga 18 Stocks Moving in Friday's Pre-Market Session January 14, 2022 Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc... Via Benzinga RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance January 13, 2022 RedHill Biopharma Ltd (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients. The... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 30, 2021 Gainers Kiora Pharmaceuticals (NASDAQ:KPRX Via Benzinga 44 Stocks Moving In Thursday's Mid-Day Session December 30, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future... Via Benzinga 63 Biggest Movers From Yesterday December 31, 2021 Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its... Via Benzinga RedHill Announces Additional Insider Buying December 15, 2021 RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that... From RedHill Biopharma Ltd Via AccessWire Exposures COVID-19 Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday December 14, 2021 Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga RedHill Biopharma's Talicia Recommended For H. Pylori Infection December 09, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed prescribing of... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 09, 2021 Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! Via InvestorPlace Exposures Product Safety RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori December 09, 2021 RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication Despite increasing... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Anxious World Waits As Covid Vaccine Makers Address Omicron Variant December 07, 2021 Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not... Via FinancialNewsMedia Exposures COVID-19 RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations December 06, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) announced that opaganib's proposed mechanism of action is not impacted by spike protein mutations. Opaganib is expected to be... Via Benzinga Exposures COVID-19 RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations December 06, 2021 Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI December 02, 2021 RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection. The new publication, describing a ... Via Benzinga RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI December 02, 2021 RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI High Body Mass Index and obesity are known risk factors for H. Pylori eradication... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal RedHill’s Movantik Added To Medicare Formulary December 01, 2021 RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans Movantik® approved for inclusion as preferred and unrestricted... From RedHill Biopharma Ltd Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout November 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.